The Safety and Efficacy of Preoperative Immunotherapy Combined with Chemotherapy in Patients with Stage IIIA-IIIB Lung Squamous Cell Carcinoma

Objective  Data on preoperative immunotherapy combined with chemotherapy in potentially resectable lung squamous cell carcinoma (LUSC) remain scarce. This study was designed to investigate the safety and efficacy of preoperative immunotherapy and chemotherapy for stage IIIA-IIIB LUSC. Methods  This...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, He, Cheng, Liu, Jiacong, Wu, Simeng, Huang, Xuhua, Zhang, Lichen, Shu, Wenbo, Gu, Chen, Wang, Yiqing, Zhu, Linhai, Hu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076098/
https://www.ncbi.nlm.nih.gov/pubmed/36446623
http://dx.doi.org/10.1055/s-0042-1758552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076098/
https://www.ncbi.nlm.nih.gov/pubmed/36446623
http://dx.doi.org/10.1055/s-0042-1758552

Ejemplares similares